Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John J McMurray

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Journal of the American College of Cardiology|May 22, 2002
Statins and chronic heart failure: do we need a large-scale outcome trial?Henry Krum, John J McMurray
American Heart Journal|December 21, 2010
A systematic review of event rates in clinical trials in diabetes mellitus: the importance of quantifying baseline cardiovascular disease history and proteinuria and implications for clinical trial designDavid Preiss, Naveed Sattar, John J McMurray
European Journal of Heart Failure|August 1, 2015
Assessment and prevalence of pulmonary oedema in contemporary acute heart failure trials: a systematic reviewElke Platz, Pardeep S Jhund, Ross T Campbell, et al.
Diabetologia|April 27, 2016
SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?Naveed Sattar, James McLaren, Søren L Kristensen, et al.
European Journal of Heart Failure|May 31, 2017
Dynamic changes and prognostic value of pulmonary congestion by lung ultrasound in acute and chronic heart failure: a systematic reviewElke Platz, Allison A Merz, Pardeep S Jhund, et al.
Journal of Advanced Nursing|February 1, 2008
The complex nature of informal care in home-based heart failure managementAlexander M Clark, Margaret E Reid, Caroline E Morrison, et al.
Circulation|August 21, 2002
Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE)Milton Packer, Robert M Califf, Marvin A Konstam, et al.
The Lancet. Diabetes & Endocrinology|March 14, 2014
Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trialDavid Preiss, Suzanne M Lloyd, Ian Ford, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|June 22, 2016
Low YKL-40 in chronic heart failure may predict beneficial effects of statins: analysis from the controlled rosuvastatin multinational trial in heart failure (CORONA)Fizza Arain, Lars Gullestad, Ståle Nymo, et al.
European Heart Journal|April 19, 2005
Low pulse pressure is independently related to elevated natriuretic peptides and increased mortality in advanced chronic heart failureAdriaan A Voors, Colin J Petrie, Mark C Petrie, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Journal of the American College of Cardiology|May 22, 2002
Statins and chronic heart failure: do we need a large-scale outcome trial?Henry Krum, John J McMurray
American Heart Journal|December 21, 2010
A systematic review of event rates in clinical trials in diabetes mellitus: the importance of quantifying baseline cardiovascular disease history and proteinuria and implications for clinical trial designDavid Preiss, Naveed Sattar, John J McMurray
European Journal of Heart Failure|August 1, 2015
Assessment and prevalence of pulmonary oedema in contemporary acute heart failure trials: a systematic reviewElke Platz, Pardeep S Jhund, Ross T Campbell, et al.
Diabetologia|April 27, 2016
SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?Naveed Sattar, James McLaren, Søren L Kristensen, et al.
European Journal of Heart Failure|May 31, 2017
Dynamic changes and prognostic value of pulmonary congestion by lung ultrasound in acute and chronic heart failure: a systematic reviewElke Platz, Allison A Merz, Pardeep S Jhund, et al.
Journal of Advanced Nursing|February 1, 2008
The complex nature of informal care in home-based heart failure managementAlexander M Clark, Margaret E Reid, Caroline E Morrison, et al.
Circulation|August 21, 2002
Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE)Milton Packer, Robert M Califf, Marvin A Konstam, et al.
The Lancet. Diabetes & Endocrinology|March 14, 2014
Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trialDavid Preiss, Suzanne M Lloyd, Ian Ford, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|June 22, 2016
Low YKL-40 in chronic heart failure may predict beneficial effects of statins: analysis from the controlled rosuvastatin multinational trial in heart failure (CORONA)Fizza Arain, Lars Gullestad, Ståle Nymo, et al.
European Heart Journal|April 19, 2005
Low pulse pressure is independently related to elevated natriuretic peptides and increased mortality in advanced chronic heart failureAdriaan A Voors, Colin J Petrie, Mark C Petrie, et al.
Pageof 7